New data support a change in management of the common eye disease glaucoma from eye drops, the current standard of care, to a ...

MediPrint® Ophthalmics (MediPrint), a clinical-stage ophthalmic drug delivery company based in San Diego, announced the results of the Company’s Phase 2b clinical trial of LL-BMT1. Employing a novel ...

A new study presented Oct. 20 at AAO 2024, the 128th annual meeting of the American Academy of Ophthalmology, shows that ...

For glaucoma, there are two main types of laser therapy: laser trabeculoplasty and cyclophotocoagulation. Laser trabeculoplasty involves directing the laser to the trabecular meshwork, allowing ...

for open-angle and laser peripheral iridotomy (LPI) for angle-closure glaucoma. SLT is an outpatient laser procedure designed ...

About 3 million people in the United States have glaucoma, and it’s the second leading cause of blindness worldwide, ...

Glaucoma is a group of eye diseases that cause slow ... They have been shown to be effective when taken regularly. Sometimes laser treatments or surgery are also recommended to slow the disease's ...

Background Normal tension glaucoma (NTG) is commonly treated with anti-glaucoma medications. Recently, selective laser trabeculoplasty (SLT) has been demonstrated to lower the intraocular pressure ...

Ask ophthalmologist Dr. Lauren Kaplan if eye exams are important and she will give a resounding “yes.” A medical doctor ...

Glaucoma occurs due to optic nerve damage. A common treatment is prescription eye drops. Although eye drops do not cure or reverse vision loss, they can help prevent optic nerve damage. Glaucoma ...